title: Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.
authors.forename: Michael G
authors.initials: MG
authors.lastname: Ison
authors.forename: Alan S
authors.initials: AS
authors.lastname: Hollister
authors.forename: William P
authors.initials: WP
authors.lastname: Sheridan
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use*; D003517:Cyclopentanes / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use*; D015507:Drugs, Investigational / Q000008:administration & dosage*; D004638:Emergency Treatment; D005260:Female; D006146:Guanidines / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000188:drug therapy* / Q000821:virology*; D008297:Male; D011247:Pregnancy
chemical_list: D000998:Antiviral Agents; D003517:Cyclopentanes; D015507:Drugs, Investigational; D006146:Guanidines